Navigation Links
Results of Research Depends on Funding Agency

There are many agencies which are involved in different kinds of research. //People should be wary of such research findings. Each agency may come out with different results on health and nutrition based on the funding agency.

In this connection, Dr. David Ludwig of Children's Hospital Boston and Harvard University says that there are numerous groups which conduct such researches. When an industry funds a study it is the normal trend of the researcher to toe the line with their sponsors. The result of an investigation depends totally on the funding agencies. Questions are asked to the respondents accordingly.

According to Professor Martijn Katan, of Vrije University, Amsterdam, this may result in giving a different picture on nutritional and dietary component which in turn may affect the scientific aspect.

Dr Ludwig considers the topic of nutrition to be of great significance in today’s world as it deals primarily with children. According to him, children are the deciding force in any purchase and food industry especially owes a lot to them. His team has conducted around 100 studies on soft drinks, juice and milk over a period of 4 years.


JYT
'"/>




Page: 1

Related medicine news :

1. Hormone Deficiency Results In Miscarriage
2. Breast Implants May Interfere With The Interpretation Of Mammogram Results
3. DNA Testing For More Accurate Results
4. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
5. Intense Fight Against Polio In India Gets Results
6. Deadly Diarrhoea Vaccine – Trail Results Promising
7. Novartis MS Drug Shows Promising Results
8. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
9. Dealing With Stress Results In Better Academic Performance
10. Excess Intake of Alcohol Results in Permanent DNA Damage.
11. Study Reveals Better Results in Patients Suffering From Depression.
Post Your Comments:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 1Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 3Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 4Fortebio Inc to Present at UBS Global Life Sciences Conference 14190 1